| |
 |
ARTICLES 
|
|
| Epstein-Barr virus-associated B-cell lymphoproliferative disorders in immunodeficiency: meeting the challenge |
| RS Shapiro |
|
JCO Mar 1 1990: 371–373.
[PDF]
|
 |
| Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come |
| DS Ettinger |
|
JCO Mar 1 1990: 374–377.
[PDF]
|
|
|
Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies |
| |
JH Joncas, P Russo, P Brochu, P Simard, J Brisebois, J Dube, D Marton, JM Leclerc, H Hume, and GE Rivard |
| |
JCO Mar 1 1990: 378–384.
[Abstract]
[PDF]
|
|
|
Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study |
| |
M Blackstein, EA Eisenhauer, R Wierzbicki, and S Yoshida |
| |
JCO Mar 1 1990: 385–389.
[Abstract]
[PDF]
|
|
|
Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer |
| |
WK Evans, EA Eisenhauer, Y Cormier, J Ayoub, R Wierzbicki, F Laberge, and FA Shepherd |
| |
JCO Mar 1 1990: 390–395.
[Abstract]
[PDF]
|
|
|
Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation |
| |
BE Johnson, J Grayson, RW Makuch, RI Linnoila, MJ Anderson, MH Cohen, E Glatstein, JD Minna, and DC Ihde |
| |
JCO Mar 1 1990: 396–401.
[Abstract]
[PDF]
|
|
|
The clinical significance of variant-morphology small-cell carcinoma of the lung |
| |
SC Aisner, DM Finkelstein, DS Ettinger, MD Abeloff, JC Ruckdeschel, and JC Eggleston |
| |
JCO Mar 1 1990: 402–408.
[Abstract]
[PDF]
|
|
|
Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiation therapy |
| |
WJ Curran, Jr and PM Stafford |
| |
JCO Mar 1 1990: 409–415.
[Abstract]
[PDF]
|
|
|
The role of adjuvant surgery in the combined modality therapy of small- cell bronchogenic carcinoma after a chemotherapy-induced partial remission |
| |
PY Holoye, MJ McMurtrey, CF Mountain, WK Murphy, HM Dhingra, T Umsawasdi, BS Glisson, JS Lee, DT Carr, and M Valdivieso |
| |
JCO Mar 1 1990: 416–422.
[Abstract]
[PDF]
|
|
|
Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia |
| |
I Schwarzinger, P Valent, U Koller, C Marosi, B Schneider, O Haas, W Knapp, K Lechner, and P Bettelheim |
| |
JCO Mar 1 1990: 423–430.
[Abstract]
[PDF]
|
|
|
Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood |
| |
CA Felix, DG Poplack, GH Reaman, SM Steinberg, DE Cole, BJ Taylor, CG Begley, and IR Kirsch |
| |
JCO Mar 1 1990: 431–442.
[Abstract]
[PDF]
|
|
|
Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee |
| |
WM Crist, L Garnsey, MS Beltangady, E Gehan, F Ruymann, B Webber, DM Hays, M Wharam, and HM Maurer |
| |
JCO Mar 1 1990: 443–452.
[Abstract]
[PDF]
|
|
|
Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections |
| |
SJ Weisman, FJ Scoopo, GM Johnson, AJ Altman, and JJ Quinn |
| |
JCO Mar 1 1990: 453–459.
[Abstract]
[PDF]
|
|
|
Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon |
| |
RL Krigel, KA Padavic-Shaller, AR Rudolph, M Konrad, EC Bradley, and RL Comis |
| |
JCO Mar 1 1990: 460–467.
[Abstract]
[PDF]
|
|
|
Effect of tumor necrosis factor on the human fibrinolytic system [published erratum appears in J Clin Oncol 1990 Sep;8(9):1602] |
| |
P Silverman, GH Goldsmith, Jr, TR Spitzer, EH Rehmus, and NA Berger |
| |
JCO Mar 1 1990: 468–475.
[Abstract]
[PDF]
|
|
|
Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma |
| |
RG Steis, JA Carrasquillo, R McCabe, MA Bookman, JC Reynolds, SM Larson, JW Smith, 2d, JW Clark, V Dailey, and S Del Vecchio |
| |
JCO Mar 1 1990: 476–490.
[Abstract]
[PDF]
|
|
|
Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy |
| |
JH Doroshow, P Multhauf, L Leong, K Margolin, T Litchfield, S Akman, B Carr, M Bertrand, D Goldberg, and D Blayney |
| |
JCO Mar 1 1990: 491–501.
[Abstract]
[PDF]
|
|
|
High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma |
| |
JD Hainsworth, LS Burnett, HW Jones, 3d, WW Grosh, DH Johnson, and FA Greco |
| |
JCO Mar 1 1990: 502–508.
[Abstract]
[PDF]
|
|
|
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group |
| |
O Klepp, AM Olsson, H Henrikson, N Aass, O Dahl, AE Stenwig, BE Persson, E Cavallin-Stahl, SD Fossa, and L Wahlqvist |
| |
JCO Mar 1 1990: 509–518.
[Abstract]
[PDF]
|
|
|
Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group |
| |
M Castiglione, RD Gelber, and A Goldhirsch |
| |
JCO Mar 1 1990: 519–526.
[Abstract]
[PDF]
|
|
|
High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease |
| |
RJ Jones, S Piantadosi, RB Mann, RF Ambinder, EJ Seifter, HM Vriesendorp, MD Abeloff, WH Burns, WS May, and SD Rowley |
| |
JCO Mar 1 1990: 527–537.
[Abstract]
[PDF]
|
|
|
Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience |
| |
TA Alvegard, NO Berg, B Baldetorp, M Ferno, D Killander, J Ranstam, A Rydholm, and M Akerman |
| |
JCO Mar 1 1990: 538–547.
[Abstract]
[PDF]
|
|
|
Improved methodology for analyzing local and distant recurrence |
| |
R Gelman, R Gelber, IC Henderson, CN Coleman, and JR Harris |
| |
JCO Mar 1 1990: 548–555.
[Abstract]
[PDF]
|
|
|
Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia |
| |
S Cortelazzo, P Viero, G Finazzi, A D'Emilio, F Rodeghiero, and T Barbui |
| |
JCO Mar 1 1990: 556–562.
[Abstract]
[PDF]
|
|
|
The American Society of Clinical Oncology and American Society of Hematology Recommended Criteria for the Performance of Bone Marrow Transplantation |
| |
|
| |
JCO Mar 1 1990: 563–564.
[Abstract]
[PDF]
|
|
| Five-year survival of nonsmall-cell lung cancer patients after treatment with chemotherapy alone |
| GP Stathopoulos |
|
JCO Mar 1 1990: 565a–566.
[PDF]
|
|
| The missing era of breast cancer chemotherapy |
| EM Greenspan |
|
JCO Mar 1 1990: 565b.
[PDF]
|
|
